What is the treatment for otitis media?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Otitis Media

High-dose amoxicillin (80-90 mg/kg/day in 2 divided doses) is the first-line antibiotic for most patients with acute otitis media, but immediate pain management is mandatory for all patients regardless of antibiotic decision. 1

Initial Management Decision: Antibiotics vs. Observation

Immediate antibiotics are required for:

  • All children <6 months of age 1
  • Children 6-23 months with severe AOM or bilateral non-severe AOM 1
  • Children with severe symptoms (moderate-to-severe otalgia, otalgia >48 hours, or temperature ≥39°C) 1
  • When follow-up cannot be ensured 1

Observation without immediate antibiotics is appropriate for:

  • Children ≥2 years with mild-to-moderate symptoms and reliable follow-up 1, 2
  • Children 6-23 months with non-severe unilateral AOM 1
  • Observation requires a mechanism to ensure follow-up within 48-72 hours and immediate antibiotic initiation if symptoms worsen or fail to improve 1

Pain Management (Critical First Step)

Pain control must be addressed immediately in every patient, regardless of whether antibiotics are prescribed, especially during the first 24 hours. 1, 2

  • Use acetaminophen or ibuprofen 1
  • Topical analgesics may provide relief within 10-30 minutes, though evidence quality is limited 1

First-Line Antibiotic Selection

Amoxicillin 80-90 mg/kg/day in 2 divided doses is first-line for most patients due to effectiveness against common pathogens (S. pneumoniae, H. influenzae, M. catarrhalis), safety, low cost, acceptable taste, and narrow microbiologic spectrum. 1, 2

Use amoxicillin-clavulanate (90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in 2 divided doses) instead of amoxicillin as first-line when:

  • Patient received amoxicillin in the previous 30 days 1
  • Concurrent purulent conjunctivitis is present 1
  • Coverage for beta-lactamase-producing organisms (especially H. influenzae and M. catarrhalis) is needed 1

Penicillin-Allergic Patients

For non-severe penicillin allergy, use second/third-generation cephalosporins (cross-reactivity is lower than historically reported): 1

  • Cefdinir 14 mg/kg/day in 1-2 doses 1
  • Cefuroxime 30 mg/kg/day in 2 divided doses 1
  • Cefpodoxime 10 mg/kg/day in 2 divided doses 1
  • Ceftriaxone 50 mg IM or IV per day for 1-3 days 1

Treatment Duration

Duration depends on age and severity: 1, 2

  • Children <2 years and those with severe symptoms: 10-day course 1, 2
  • Children 2-5 years with mild-to-moderate AOM: 7-day course (equally effective) 1, 2
  • Children ≥6 years with mild-to-moderate symptoms: 10-day course 1

Treatment Failure Management

If symptoms worsen or fail to improve within 48-72 hours:

  • Reassess to confirm AOM diagnosis 1, 2
  • Switch to amoxicillin-clavulanate if initial treatment was amoxicillin 1, 2
  • If already on amoxicillin-clavulanate, use intramuscular ceftriaxone 50 mg/kg/day for 1-3 days 1
  • A 3-day course of ceftriaxone is superior to a 1-day regimen for AOM unresponsive to initial antibiotics 1, 3

Common pitfall: The predominant pathogens in treatment failure are beta-lactamase-producing organisms, particularly H. influenzae. 4

Multiple Treatment Failures

For children with multiple treatment failures, consider tympanostomy tube placement with culture and susceptibility testing. 1, 2

Post-Treatment Middle Ear Effusion

After successful antibiotic treatment, middle ear effusion is common and expected: 1

  • 60-70% of children have effusion at 2 weeks 1
  • 40% at 1 month 1
  • 10-25% at 3 months 1

This is defined as otitis media with effusion (OME) and requires monitoring but NOT antibiotics. 1, 2

Special Case: AOM with PE Tube in Place

Topical fluoroquinolone antibiotics (ofloxacin or ciprofloxacin) are first-line for acute tube otorrhea when a functioning PE tube is present. 5

  • Oral antibiotics are generally unnecessary when the tube is functioning and allowing drainage 5
  • Never use aminoglycoside-containing drops when a PE tube is present due to ototoxicity 5
  • Consider oral antibiotics only for systemic symptoms (high fever, severe illness, mastoiditis signs) or failure of topical therapy after 48-72 hours 5

Prevention Strategies

Modifiable risk factors to address: 1, 2

  • Encourage breastfeeding for at least 6 months 1
  • Reduce or eliminate pacifier use after 6 months of age 1
  • Avoid supine bottle feeding 1
  • Eliminate tobacco smoke exposure 1, 2
  • Minimize daycare attendance when possible 1

Vaccination: 1, 2

  • Pneumococcal conjugate vaccine (PCV-13) 1, 2
  • Annual influenza vaccination 1

Long-term prophylactic antibiotics are discouraged for recurrent AOM. 1

What NOT to Do

Corticosteroids (including prednisone) should NOT be routinely used in the treatment of acute otitis media as current evidence does not support their effectiveness. 1

Critical pitfall: Antibiotics do not eliminate the risk of complications like acute mastoiditis—33-81% of mastoiditis patients had received prior antibiotics. 1

References

Guideline

Treatment of Acute Otitis Media

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Otitis Media Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Otitis Media with PE Tube in Place

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.